Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP769728.RAFzEBC4593MuPOPh17HLCEnn1q8z7MXD9NY2j1g6XGQI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP769728.RAFzEBC4593MuPOPh17HLCEnn1q8z7MXD9NY2j1g6XGQI130_assertion type Assertion NP769728.RAFzEBC4593MuPOPh17HLCEnn1q8z7MXD9NY2j1g6XGQI130_head.
- NP769728.RAFzEBC4593MuPOPh17HLCEnn1q8z7MXD9NY2j1g6XGQI130_assertion description "[In 1991 we described a familial variety of primary hyperaldosteronism which was not glucocorticoid-suppressible and was associated with adenoma formation, and called it familial hyperaldosteronism type II (FH-II) in order to distinguish it from the glucocorticoid-suppressible variety described in 1966, familial hyperaldosteronism type I (FH-I).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP769728.RAFzEBC4593MuPOPh17HLCEnn1q8z7MXD9NY2j1g6XGQI130_provenance.
- NP769728.RAFzEBC4593MuPOPh17HLCEnn1q8z7MXD9NY2j1g6XGQI130_assertion evidence source_evidence_literature NP769728.RAFzEBC4593MuPOPh17HLCEnn1q8z7MXD9NY2j1g6XGQI130_provenance.
- NP769728.RAFzEBC4593MuPOPh17HLCEnn1q8z7MXD9NY2j1g6XGQI130_assertion SIO_000772 7882585 NP769728.RAFzEBC4593MuPOPh17HLCEnn1q8z7MXD9NY2j1g6XGQI130_provenance.
- NP769728.RAFzEBC4593MuPOPh17HLCEnn1q8z7MXD9NY2j1g6XGQI130_assertion wasDerivedFrom befree-20140225 NP769728.RAFzEBC4593MuPOPh17HLCEnn1q8z7MXD9NY2j1g6XGQI130_provenance.
- NP769728.RAFzEBC4593MuPOPh17HLCEnn1q8z7MXD9NY2j1g6XGQI130_assertion wasGeneratedBy ECO_0000203 NP769728.RAFzEBC4593MuPOPh17HLCEnn1q8z7MXD9NY2j1g6XGQI130_provenance.